科源制药 (301281.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(科源制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 146,276,963.82106,903,557.02116,205,291.50100,248,710.13124,226,061.67110,738,334.24113,428,452.99
 营业收入(元) 146,276,963.82106,903,557.02116,205,291.50100,248,710.13124,226,061.67110,738,334.24113,428,452.99
二、营业总成本(元) 124,459,548.73104,437,946.99103,706,448.1683,782,321.5989,130,543.2883,487,814.2582,896,009.48
 营业成本(元) 85,598,444.1665,259,306.1564,587,769.2849,186,005.0857,058,866.3966,068,199.3566,871,881.71
 研发费用(元) 8,784,714.8014,028,477.6514,369,655.137,350,954.408,110,172.855,576,942.954,593,419.18
 营业税金及附加(元) 1,566,297.031,119,882.911,038,715.371,280,587.091,404,127.091,321,441.09979,886.74
 销售费用(元) 20,930,375.4217,974,638.1314,339,445.0216,671,922.5714,413,879.744,796,991.204,848,066.82
 管理费用(元) 8,510,046.787,599,471.259,649,198.8011,633,770.678,828,374.316,183,622.365,383,532.12
 财务费用(元) -930,329.46-1,543,829.10-278,335.44-2,340,918.22-684,877.10-459,382.70219,222.91
  其中:利息收入(元) 1,276,190.62831,092.231,101,533.91----
 资产减值损失(元) -2,840.70-3,279,519.34--73,891.05-23,762.06-717,766.81-50,434.50
 信用减值损失(元) -1,703,932.59544,644.26-1,129,214.19844,741.68-375,183.96-803,309.22-1,071,414.70
三、其他经营收益
 加:公允价值变动收益(元) 1,017,373.16-3,686,697.113,797,278.39----
 加:投资收益(元) 540,743.9610,526,365.501,326,081.41----
 资产处置收益(元) -334,510.69-----
 其他收益(元) 2,759,649.861,523,774.46562,774.801,050,299.54855,316.112,050,910.901,213,598.62
四、营业利润(元) 24,428,408.788,428,688.4917,055,763.7519,080,235.9335,551,888.4827,780,354.8630,624,192.93
 加:营业外收入(元) -78,823.9096,224.78-3,539.64141,859.09-697,198.00889,860.46
 减:营业外支出(元) 1,199,361.42115,373.18296,873.55228,185.2154,455.12129,090.338,397.77
五、利润总额(元) 23,229,047.368,392,139.2116,855,114.9818,848,511.0835,639,292.4526,954,066.5331,505,655.62
 减:所得税费用(元) 1,705,284.30-2,092,470.421,504,730.34-267,271.173,550,629.823,336,142.584,057,660.39
六、净利润(元) 21,523,763.0610,484,609.6315,350,384.6419,115,782.2532,088,662.6323,617,923.9527,447,995.23
(一)按经营持续性分类
  持续经营净利润(元) 21,523,763.0610,484,609.6315,350,384.6419,115,782.2532,088,662.6323,617,923.9527,447,995.23
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 21,532,537.0310,484,609.6315,350,384.6419,115,782.2532,088,662.6323,617,923.9527,447,995.23
  少数股东损益(元) -8,773.97------
 扣除非经常性损益后的净利润(元) 19,904,832.445,851,232.7010,651,949.7317,675,077.7531,272,472.6522,504,300.0025,553,000.00
七、每股收益
 一、基本每股收益(元) 0.200.090.13-0.010.550.410.47
 二、稀释每股收益(元) 0.200.090.13-0.010.550.410.47
九、综合收益总额(元) 21,523,763.0610,484,609.6315,350,384.6419,115,782.2532,088,662.6323,617,923.9527,447,995.23
 归属于母公司所有者的综合收益总额(元) 21,532,537.0310,484,609.6315,350,384.6419,115,782.2532,088,662.6323,617,923.9527,447,995.23
 归属于少数股东的综合收益总额(元) -8,773.97------
公告日期 2024-04-222024-03-292023-10-262023-08-222023-04-262022-09-282023-04-26
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院